Financial costs associated with monopolies on biologic medicines in Australia.
Document Type
Journal Article
Publication Date
2-1-2019
Journal
Australian Health Review : A Publication of the Australian Hospital Association
Volume
43
Issue
1
Inclusive Pages
36-40
DOI
10.1071/AH17031
Keywords
Australia; Biosimilar Pharmaceuticals; Costs and Cost Analysis; Drug Costs; Health Expenditures; Humans; Retrospective Studies
APA Citation
Gleeson, D., Townsend, B., Lopert, R., Lexchin, J., & Moir, H. (2019). Financial costs associated with monopolies on biologic medicines in Australia.. Australian Health Review : A Publication of the Australian Hospital Association, 43 (1). http://dx.doi.org/10.1071/AH17031
Peer Reviewed
1
